Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. 1984

T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos

The responses of plasma immunoreactive ACTH (IR-ACTH), cortisol, GH, PRL, and LH to a single iv injection of 0.01-5 micrograms/kg human corticotropin-releasing factor (hCRF) were investigated in healthy volunteers. The lowest effective dose of hCRF was 0.5 micrograms/kg. hCRF caused brief pulse-like elevations of plasma IR-ACTH and cortisol without any effect on the plasma concentrations of GH, PRL, and LH. By contrast, ovine CRF (oCRF), given for comparison, produced long-lasting stimulation of the human pituitary-adrenal axis. The difference in duration of effect between hCRF and oCRF may be attributed to an approximately 3-4 times higher MCR of hCRF [7.9 +/- 1.2 (+/- SE) ml/kg min; n = 14] than oCRF (1.9 +/- 0.1 ml/kg min; n = 9) in man. No serious side effects occurred at any of the doses of hCRF tested. The highest dose (5 micrograms/kg) caused a slight increase of heart rate that was not associated with significant changes in arterial blood pressure. All subjects receiving 5 micrograms/kg and one third of the subjects receiving 1 micrograms/kg hCRF experienced a transient facial flush. We conclude that hCRF causes brief plasma ACTH and cortisol secretory episodes in man, similar to the physiological plasma ACTH and cortisol secretory episodes. This is in contrast to oCRF, which causes prolonged ACTH and cortisol secretion. These differences between the two peptides may be explained by the higher MCR of hCRF than oCRF.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
March 1983, The Journal of clinical investigation,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
July 1987, Pediatric research,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
January 1988, The Journal of clinical endocrinology and metabolism,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
January 1984, The Journal of clinical endocrinology and metabolism,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
November 1989, Endocrine reviews,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
November 1989, Endocrinology,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
May 1989, The Journal of clinical endocrinology and metabolism,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
August 1983, The Journal of clinical endocrinology and metabolism,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
December 1983, The Journal of clinical endocrinology and metabolism,
T H Schürmeyer, and P C Avgerinos, and P W Gold, and W T Gallucci, and T P Tomai, and G B Cutler, and D L Loriaux, and G P Chrousos
June 1984, Acta medica Okayama,
Copied contents to your clipboard!